Akero Therapeutics, Inc.
AKRO
$54.63
-$0.06-0.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.87% | -2.35% | -24.05% | 35.10% | 29.30% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -43.63% | 40.90% | 252.70% | 174.34% | 39.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.02% | -1.47% | -21.74% | 37.58% | 29.67% |
|
|
|||||
| Total Current Assets | 1.02% | -1.47% | -21.74% | 37.58% | 29.67% |
| Net Property, Plant & Equipment | -33.89% | -31.00% | -28.45% | -26.41% | -23.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 23.00% | 28.22% | 26.70% | 42.33% | 28.68% |
|
|
|||||
| Total Accounts Payable | -19.13% | -9.05% | -21.42% | 28.26% | 120.21% |
| Total Accrued Expenses | 51.27% | 103.39% | 53.44% | 160.17% | 20.99% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.66% | 4,921.09% | 11.99% | -44.25% | 12.30% |
| Total Finance Division Other Current Liabilities | 60.63% | 139.83% | -7.24% | -- | 37.55% |
| Total Other Current Liabilities | 60.63% | 139.83% | -7.24% | -- | 37.55% |
| Total Current Liabilities | 10.07% | 93.75% | 40.25% | 107.83% | 52.18% |
|
|
|||||
| Total Current Liabilities | 10.07% | 93.75% | 40.25% | 107.83% | 52.18% |
| Long-Term Debt | -- | -36.61% | -17.22% | 41.39% | 54.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -52.23% | -45.21% | -39.87% | -35.41% | -31.87% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 143.90% | 66.29% | 259.26% | 118.28% |
| Total Liabilities | -39.49% | 24.42% | 9.10% | 68.52% | 51.78% |
|
|
|||||
| Common Stock & APIC | 34.34% | 34.45% | 34.32% | 42.03% | 35.35% |
| Retained Earnings | -38.73% | -41.55% | -42.94% | -43.91% | -45.72% |
| Treasury Stock & Other | -13.17% | 478.54% | 1,473.42% | 251.11% | 515.61% |
| Total Common Equity | 29.70% | 28.54% | 28.08% | 40.13% | 26.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 29.70% | 28.54% | 28.08% | 40.13% | 26.61% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 29.70% | 28.54% | 28.08% | 40.13% | 26.61% |
|
|
|||||